With the gradual development of artificial intelligence in various fields, the author will make a series of reports on typical cases, investment and financing, and industrial layout in the AI+ medical and health field at home and abroad for reference by investors and entrepreneurs in the industry.
This article introduces the reader to an American artificial intelligence startup company that applies deep learning technology to medical systems and is compatible with wearable devices to achieve accurate warnings before the onset of patients, typical for AI+ medical health. One of the cases.
Do you believe? By uploading a brain MRI image, you can predict how likely you are to develop Alzheimer's disease in the future. This thing sounds a bit cool, but a company founded in 2015 may be able to do it in the near future.
Headquartered in London, Avalon AI is committed to combating age-related diseases, especially neurodegenerative diseases such as Alzheimer's disease (Alzheimer's disease). They use deep learning technology to develop computer medical imaging diagnostic tools, and the current effective prediction accuracy for Alzheimer's has reached 75%.
.jpg)
Upload the brain scan image to determine brain age and condition
"Our ultimate goal is to treat aging." Avalon AI's goals are ambitious. One of the founders, Alejandro Grabotevsky, said: "It makes sense to solve the problem of aging. If you are no longer aging, you have the time around the world to solve all other important issues."
Founder of like-minded
The company's founders are two like-minded boys: Olivier van den Biggelaar and Alejandro Vicente Grabovetsky. They are all from the famous university. Olivier van den Biggelaar is a software engineer who worked on a large video streaming platform during his Ph.D. at the University of Brussels and built a complex machine learning system. In a Belgian business plan competition, Olivier received the top two results (10,000 € bonus).
.png)
Founder Olivier van den Biggelaar (left) and Alejandro Vicente Grabovetsky (right)
Another founder, Alejandro Vicente Grabovetsky, a Ph.D. student at Cambridge University and a postdoctoral fellow at the University of Mehren in the Netherlands, has been actively involved in the development of neuroimaging machines and is now widely used in laboratories around the world. The exchange award is a cognitive neurologist.
They have always had a common wish to overcome ageing diseases. The two immediately planned to turn this beautiful vision into reality, so they had the idea of ​​creating Avalon AI (Avalon Avalon is the country of the Celtic legend, the land of longevity). Following this line of thinking, they found that research on age-related diseases such as diabetes and cancer has many fund support and is often emphasized by the medical community; while the fund for Alzheimer's disease is rare, in part because the disease has been Without a successful solution, the failure rate of clinical trials is too high. Others are reluctant to retreat, and they must face difficulties!
Their research on the direction of Alzheimer's disease actually stems from a very personal reason: the grandmother of both people is suffering from Alzheimer's. Avalon AI's homepage reads: "The most terrifying of the old age is a neurodegenerative disease like Alzheimer's. Once sick, our identity and personal dignity will be gradually deprived. There is nothing left in the score." This kind of pain may be witnessed by the loved ones suffering from this incurable disease, in order to have some experience.
Dried Garlic Powder,Dried Minced Garlic To Garlic Powder,Garlic Dry Powder,Sun Dried Garlic Powder
shandong changrong international trade co.,ltd. , https://www.changronggarliccn.com